98694731 - SUTRO

Information

• Trademark
• 98694731

• Source

• Serial Number

  98694731

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 12, 2024
  a year ago

• Transaction Date

  July 23, 2025
  4 months ago

• Status Date

  July 22, 2025
  4 months ago

• Published for Opposition Date

  May 27, 2025
  5 months ago

• Location Date

  July 22, 2025
  4 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  PATTERSON,MARY A

• Attorney Docket Number

  061884-400

  Attorney Name

  Karen Won

  Law Office Assigned Location Code

  T20

• Owners

  • SUTRO BIOPHARMA, INC,

Case File Statements

• GS0401: Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations.
• GS0051: Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use
• GS0421: Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases.

Case File Event Statements

• 8/12/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/16/2025 - 10 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/19/2025 - 9 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/20/2025 - 9 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/20/2025 - 9 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/22/2025 - 7 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/22/2025 - 7 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/25/2025 - 6 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/21/2025 - 6 months ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/27/2025 - 5 months ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/27/2025 - 5 months ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/22/2025 - 4 months ago

  14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 2/20/2025 - 9 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/22/2025 - 7 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA